As of 3:44pm ET
| -0.11 / -5.47%|
The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 480.00, with a high estimate of 480.00 and a low estimate of 480.00. The median estimate represents a +25,163.16% increase from the last price of 1.90.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.